|
1
|
Durfee RA, Mohammed M and Luu HH: Review
of osteosarcoma and current management. Rheumatol Ther. 3:221–243.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lindsey BA, Markel JE and Kleinerman ES:
Osteosarcoma overview. Rheumatol Ther. 4:25–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin YH, Jewell BE, Gingold J, Lu L, Zhao
R, Wang LL and Lee DF: Osteosarcoma: Molecular pathogenesis and
iPSC modeling. Trends Mol Med. 23:737–755. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Perkel JM: Visiting ‘noncodarnia’.
Biotechniques. 54:301, 303–304. 2013. View Article : Google Scholar
|
|
7
|
Li J, Zhang M, An G and Ma Q: LncRNA TUG1
acts as a tumor suppressor in human glioma by promoting cell
apoptosis. Exp Biol Med (Maywood). 241:644–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu Y, Wang J, Qiu M and Xu L, Li M, Jiang
F, Yin R and Xu L: Upregulation of the long noncoding RNA TUG1
promotes proliferation and migration of esophageal squamous cell
carcinoma. Tumor Biol. 36:1643–1651. 2015. View Article : Google Scholar
|
|
9
|
Ma B, Li M, Zhang L, Huang M, Lei JB, Fu
GH, Liu CX, Lai QW, Chen QQ and Wang YL: Upregulation of long
non-coding RNA TUG1 correlates with poor prognosis and disease
status in osteosarcoma. Tumor Biol. 37:4445–4455. 2016. View Article : Google Scholar
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thai P, Statt S, Chen CH, Liang E,
Campbell C and Wu R: Characterization of a novel long noncoding
RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer
cell lines. Am J Respir Cell Mol Biol. 49:204–211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang L, Zhao Z, Feng W, Ye Z, Dai W, Zhang
C, Peng J and Wu K: Long non-coding RNA TUG1 promotes colorectal
cancer metastasis via EMT pathway. Oncotarget. 7:51713–51719.
2016.PubMed/NCBI
|
|
13
|
Kansara M and Thomas DM: Molecular
pathogenesis of osteosarcoma. DNA Cell Biol. 26:1–18. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X and Yan GY: Novel human
lncRNA-disease association inference based on lncRNA expression
profiles. Bioinformatics. 29:2617–2624. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yun-Bo F, Xiao-Po L, Xiao-Li L, Guo-Long
C, Pei Z and Fa-Ming T: LncRNA TUG1 is upregulated and promotes
cell proliferation in osteosarcoma. Open Med (Wars). 11:163–167.
2016.PubMed/NCBI
|
|
16
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hori SS, Lutz AM, Paulmurugan R and
Gambhir SS: Correlation of plasma biomarker levels with early-stage
tumor viability in an orthotopic ovarian cancer mouse model. Cancer
Res. 74 (19 Suppl):Abstract nr 873. 2014.PubMed/NCBI
|
|
18
|
Wang Z, Tan M, Chen G, Li Z and Lu X:
LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma
patients and regulates osteosarcoma cells proliferation and
motility through modulating SOX2. IUBMB Life. 69:867–876. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang M, Lu W, Huang Y, Shi J, Wu X, Zhang
X, Jiang R, Cai Z and Wu S: Downregulation of the long noncoding
RNA TUG1 inhibits the proliferation, migration, invasion and
promotes apoptosis of renal cell carcinoma. J Mol Histol.
47:421–428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rokavec M, Öner MG, Li H, Jackstadt R,
Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et
al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated
colorectal cancer invasion and metastasis. J Clin Invest.
124:1853–1867. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martin JW, Zielenska M, Stein GS, van
Wijnen AJ and Squire JA: The role of RUNX2 in osteosarcoma
oncogenesis. Sarcoma. 2011:2827452011. View Article : Google Scholar : PubMed/NCBI
|
